Nitrosourea-based chemotherapy in optic pathway glioma with progressive visual loss

References

• Lee AG, Dutton J. A practice pathway for the management of gliomas of the anterior visual pathway: an update and an evidence-based approach. Neuro-ophthalmology. 1999;22(3): 139–155.
   Web of Science ®Google Scholar
• Alshail E, Rutka JT, Becker LE, et al. Optic chiasmatic-hypothalamic glioma. Brain Pathol. 1997;7: 799–806.
   PubMed Web of Science ®Google Scholar
• Bognanno JR, Edwards MK, Lee TT, et al. Cranial MR imaging in neurofibromatosis. Am J Radiol. 1988;151:381–388.
   Google Scholar
• Beyer RA, Pader P, Sobel DF, et al. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology. I 986;36:1173-1178.
   Google Scholar
• Bleyer WA, Griffin TW. White matter necrosis, microangiopathy and intellectual abilities in survivors of childhood leukemia: associations with central nervous system irradiation and methotrexate therapy. In: Gilbert A, editor. Radiation damage to the nervous system. New York: Raven Press, 1980;155–174.
   Google Scholar
• Davis PC, Hoffman JC, Pearl GS, et al. CT evaluation of effects of cranial radiation therapy in children. Am J Neuro-Radiol. 1986;7:639–644.
   Web of Science ®Google Scholar
• Epstein MA, Packer RJ, Rorke LB, et al. Vascular malformation with radiation vasculopathy after treatment of chiasmatic hypothalamic glioma. Cancer. 1992;70:887–893.
   PubMed Web of Science ®Google Scholar
• Gould RJ, Hilal SK, Chutorian AM. Efficacy of radiotherapy in optic gliomas. Pediatr Neurol. 1987;3: 29–32.
   PubMed Web of Science ®Google Scholar
• Kestle JRW, Hoffman HJ, Mock AR. Moya moya phenomenon after radiation for optic glioma. J Neurosurg. 1993;79:32–35.
   Google Scholar
• Martins AN, Johnston JS, Henry JIM, et al. Delayed radiation necrosis of the brain. J Neurosurg. 1977;47: 336–345.
   PubMed Web of Science ®Google Scholar
• Okuno T, Prensky AL, Gado M. The Moyamoya syndrome associated with irradiation of optic glioma in children: report of two cases and review of the literature. Pediatr Neurol. 1985;1:311–316.
   Google Scholar
• Packer RJ, Savino PJ, Bilaniuk LT, et al. Chiasmatic gliomas of childhood. A reappraisal of natural history and effectiveness of cranial irradiation. Child's Brain. 1983;10: 393–403.
   Google Scholar
• Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res. 1989;25:561–567.
   PubMed Web of Science ®Google Scholar
• Sayli T, Cemeroglu AP, Tuncer AM. Acute lympoblastic leukemia following optic glioma treated by radiotherapy and surgery. Acta Paediatr. 1993;82:327–328.
   Google Scholar
• Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: surveillance or irradiation? Int J Radiat Oncol Biol Phys. 1993;25: 215–225.
   Google Scholar
• Hoffman HJ, Humphreys RP, Drake JM, et al. Optic pathway/hypothalamic gliomas. A dilemma in management. Neurosurgery. 1993;19:186–195.
   Google Scholar
• Lassman LP, Pearce GW, Gang J. Effect of vincristine sulfate on the intracranial gliomata of childhood. Br J Surg. 1966;53:774–777.
   Google Scholar
• Moghrabi A, Friedman HS, Burger PC, et al. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg. 1993;79:223–227.
   PubMed Web of Science ®Google Scholar
• Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmal/ hypothalalmic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988;23:79–85.
   PubMed Web of Science ®Google Scholar
• Packer RJ, Large B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Guth Oncol. 1993;11:850–856.
   Google Scholar
• Packer RJ, Ater JC, Phillips P, et al. Efficacy of chemotherapy for children with newly diagnosed progressive low-grade gliomas (abstract). Ann Neurol. 1994;36:496.
   Google Scholar
• Rosenstock JG, Audrey EE, Schut L. Response to vincristine of recurrent brain tumors in children. J Neurosurg. 1976;45:135–140.
   Google Scholar
• Rosenstock JG, Packer RJ, Bilaniuk L, et al. Chiasmatic optic glioma treated with chemotherapy: a preliminary report. J Neurosurg. 1985;63:862–866.
   PubMed Web of Science ®Google Scholar
• Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/ chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer. 1995;75: 1052–1059.
   Web of Science ®Google Scholar
• Sutton LN. Visual pathway gliomas of childhood. Neurosurgery. 1994; 16:1–6.
   Google Scholar
• Sutton LN, Molloy PT, Senyak H. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg. 1995;83:583–589.
   Google Scholar
• Lefkowitz TB, Packer RJ, Sutton LN, et al. Results of treatment of children with recurrent gliomas with lomustine and vincristine. Cancer. 1998;61:896–902.
   Google Scholar
• Petronio J, Edwards MSB, Prados M, et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg. 1991;74:701–708.
   Google Scholar
• Silva MM, Goldman S, Keating G, et al. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg. 2000;33:151–158.
   Google Scholar
• Aquino VM, Fort DW, Kamen BA. Carboplatin for the treatment of children with newly diagnosed optic chiasm gliomas: a phase II study. J Neuro-oncol. 1999;41(3): 255–259.
   Google Scholar
• Prados MD, Edwards MSB, Rabbitt J, et al. Treatment of pediatric low grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neuro-oncol. 1997;32: 235–241.
   PubMed Web of Science ®Google Scholar
• DeSousa AL, Kalsbeck JE, Mealey Jr J, et al. Optic chiasmatic glioma in children. Am J Ophthalmol. 1979;87: 376–381.
   PubMed Web of Science ®Google Scholar
• Kryitsis AP, Yung WKA, Jaeckle KA, et al. Combination of 6-thiguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas. Neurosurgery. 1996;39:921–926.
   Google Scholar
• Levin VA, Lamborn K, Wara W, et al. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, loustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Neuro-oncology. 2000;2:22–28
   PubMed Web of Science ®Google Scholar